Axios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The ...

I tried anti-obesity medication and these were the surprising side-effects' - When Henry Conway hit his forties his BMI ...

I applaud the Biden administration’s recent moves to make these anti-obesity drugs more accessible to people on Medicaid and ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

TV star and comedian Katherine Ryan has responded to claims from her teenage daughter that she has been using controversial ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

The Food and Drug Administration on Friday approved Eli Lilly’s anti-obesity drug Zepbound as the first prescription medicine for obstructive sleep apnea, marking a major shift in the treatment ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

Taking a glp-1 medication for weight loss isn't appropriate for everyone. There are side effects and costs to consider.

I am 5 weeks into Mounjaro, the weekly injectable medication that contains Tirzepatide, an active ingredient that supresses and regulates your appetite. Ozempic is perhaps the more famous ...